Literature DB >> 15043051

A new instrument for pain assessment in vulvar vestibulitis syndrome.

Caroline F Pukall1, Yitzchak M Binik, Samir Khalifé.   

Abstract

Vulvar vestibulitis syndrome (VVS) is a common form of dyspareunia in premenopausal women. The standard test for diagnosing VVS is the cotton-swab test, during which a cotton-swab is applied to various locations of the vulvar vestibule. However, there is much variation in the implementation of this test relating to the precise vestibular locations palpated, the order of palpation, and the force used during palpation. We introduce a new simple, mechanical device, a vulvalgesiometer, to standardize genital pain assessment and present promising preliminary data from women with VVS and nonaffected women. These data indicate that women with VVS have significantly lower vestibular pain thresholds compared with control women. During painful vulvar stimulation with the vulvalgesiometer, women with VVS described the pain with adjectives similar to those used to describe their intercourse pain (e.g., burning). This novel device has several important implications for genital pain measurement in women who suffer from urogenital pain.

Entities:  

Mesh:

Year:  2004        PMID: 15043051     DOI: 10.1080/00926230490275065

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  12 in total

Review 1.  [Review of the literature on the psychoemotional reality of women with vulvodynia: difficulties met and strategies developed].

Authors:  M Cantin-Drouin; D Damant; D Turcotte
Journal:  Pain Res Manag       Date:  2008 May-Jun       Impact factor: 3.037

2.  Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis.

Authors:  Denniz Zolnoun; Eric Bair; Greg Essick; Richard Gracely; Vinita Goyal; William Maixner
Journal:  J Pain       Date:  2012-09       Impact factor: 5.820

3.  MicroRNA expression profiles differentiate chronic pain condition subtypes.

Authors:  Brittney P Ciszek; Asma A Khan; Hong Dang; Gary D Slade; Shad Smith; Eric Bair; William Maixner; Denniz Zolnoun; Andrea G Nackley
Journal:  Transl Res       Date:  2015-06-24       Impact factor: 7.012

4.  Psychosocial Factors Influence Sexual Satisfaction among Women with Vulvodynia.

Authors:  Jennifer Jo Connor; Miriam Haviland; Sonya S Brady; Beatrice Bean E Robinson; Bernard L Harlow
Journal:  J Sex Marital Ther       Date:  2020-05-28

5.  Somatization and psychological distress among women with vulvar vestibulitis syndrome.

Authors:  Denniz Zolnoun; Eliza M Park; Charity G Moore; Cara A Liebert; Frank F Tu; Sawson As-Sanie
Journal:  Int J Gynaecol Obstet       Date:  2008-07-16       Impact factor: 3.561

6.  The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness.

Authors:  David C Foster; Merrill Beth Kotok; Li-Shan Huang; Arthur Watts; David Oakes; Fred M Howard; Chris J Stodgell; Robert H Dworkin
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

7.  GCH1-polymorphism and pain sensitivity among women with provoked vestibulodynia.

Authors:  Ulrika Heddini; Nina Bohm-Starke; Alfhild Grönbladh; Fred Nyberg; Kent W Nilsson; Ulrika Johannesson
Journal:  Mol Pain       Date:  2012-09-12       Impact factor: 3.395

8.  Brain responses to vestibular pain and its anticipation in women with Genito-Pelvic Pain/Penetration Disorder.

Authors:  Els Pazmany; Huynh Giao Ly; Leen Aerts; Michiko Kano; Sophie Bergeron; Johan Verhaeghe; Ronald Peeters; Jan Tack; Patrick Dupont; Paul Enzlin; Lukas Van Oudenhove
Journal:  Neuroimage Clin       Date:  2017-07-25       Impact factor: 4.881

9.  How Does Myofascial Physical Therapy Attenuate Pain in Chronic Pelvic Pain Syndrome?

Authors:  Keren Grinberg; Irit Weissman-Fogel; Lior Lowenstein; Liora Abramov; Michal Granot
Journal:  Pain Res Manag       Date:  2019-12-12       Impact factor: 3.037

10.  Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases.

Authors:  Andrew T Goldstein; Michelle A King
Journal:  Sex Med       Date:  2016-06-29       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.